Global Pharmacokinetics Services Market Size, Status and Forecast 2020-2026

Published On: Mar 2020

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 421103

This report focuses on the global Pharmacokinetics Services status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmacokinetics Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Evotec AG (Germany)
Pacific BioLabs (US)
GVK Biosciences Private Limited (India)
Shanghai Medicilon Inc. (China)
Pharmaceutical Product Development, LLC (US)
Charles River Laboratories International, Inc. (US)
PAREXEL International Corporation (US)
Eurofins Scientific, Inc. (Luxembourg)
Frontage Labs (US)
SGS SA (Switzerland)
LGC Limited (UK)
Creative Bioarray (US)
Certara, L.P. (Germany)

Market segment by Type, the product can be split into
Small Molecules Pharmacokinetics Services
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
Market segment by Application, split into
Small & Medium Enterprise
Large Enterprise

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pharmacokinetics Services status, future forecast, growth opportunity, key market and key players.
To present the Pharmacokinetics Services development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pharmacokinetics Services are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacokinetics Services Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmacokinetics Services Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Small Molecules Pharmacokinetics Services
1.4.3 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
1.5 Market by Application
1.5.1 Global Pharmacokinetics Services Market Share by Application: 2020 VS 2026
1.5.2 Small & Medium Enterprise
1.5.3 Large Enterprise
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Pharmacokinetics Services Market Perspective (2015-2026)
2.2 Pharmacokinetics Services Growth Trends by Regions
2.2.1 Pharmacokinetics Services Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacokinetics Services Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacokinetics Services Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmacokinetics Services Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmacokinetics Services Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Services Players by Market Size
3.1.1 Global Top Pharmacokinetics Services Players by Revenue (2015-2020)
3.1.2 Global Pharmacokinetics Services Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmacokinetics Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacokinetics Services Market Concentration Ratio
3.2.1 Global Pharmacokinetics Services Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Services Revenue in 2019
3.3 Pharmacokinetics Services Key Players Head office and Area Served
3.4 Key Players Pharmacokinetics Services Product Solution and Service
3.5 Date of Enter into Pharmacokinetics Services Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Pharmacokinetics Services Historic Market Size by Type (2015-2020)
4.2 Global Pharmacokinetics Services Forecasted Market Size by Type (2021-2026)

5 Pharmacokinetics Services Breakdown Data by Application (2015-2026)
5.1 Global Pharmacokinetics Services Market Size by Application (2015-2020)
5.2 Global Pharmacokinetics Services Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmacokinetics Services Market Size (2015-2020)
6.2 Pharmacokinetics Services Key Players in North America (2019-2020)
6.3 North America Pharmacokinetics Services Market Size by Type (2015-2020)
6.4 North America Pharmacokinetics Services Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pharmacokinetics Services Market Size (2015-2020)
7.2 Pharmacokinetics Services Key Players in Europe (2019-2020)
7.3 Europe Pharmacokinetics Services Market Size by Type (2015-2020)
7.4 Europe Pharmacokinetics Services Market Size by Application (2015-2020)

8 China
8.1 China Pharmacokinetics Services Market Size (2015-2020)
8.2 Pharmacokinetics Services Key Players in China (2019-2020)
8.3 China Pharmacokinetics Services Market Size by Type (2015-2020)
8.4 China Pharmacokinetics Services Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pharmacokinetics Services Market Size (2015-2020)
9.2 Pharmacokinetics Services Key Players in Japan (2019-2020)
9.3 Japan Pharmacokinetics Services Market Size by Type (2015-2020)
9.4 Japan Pharmacokinetics Services Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pharmacokinetics Services Market Size (2015-2020)
10.2 Pharmacokinetics Services Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacokinetics Services Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacokinetics Services Market Size by Application (2015-2020)

11 India
11.1 India Pharmacokinetics Services Market Size (2015-2020)
11.2 Pharmacokinetics Services Key Players in India (2019-2020)
11.3 India Pharmacokinetics Services Market Size by Type (2015-2020)
11.4 India Pharmacokinetics Services Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pharmacokinetics Services Market Size (2015-2020)
12.2 Pharmacokinetics Services Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacokinetics Services Market Size by Type (2015-2020)
12.4 Central & South America Pharmacokinetics Services Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Evotec AG (Germany)
13.1.1 Evotec AG (Germany) Company Details
13.1.2 Evotec AG (Germany) Business Overview and Its Total Revenue
13.1.3 Evotec AG (Germany) Pharmacokinetics Services Introduction
13.1.4 Evotec AG (Germany) Revenue in Pharmacokinetics Services Business (2015-2020))
13.1.5 Evotec AG (Germany) Recent Development
13.2 Pacific BioLabs (US)
13.2.1 Pacific BioLabs (US) Company Details
13.2.2 Pacific BioLabs (US) Business Overview and Its Total Revenue
13.2.3 Pacific BioLabs (US) Pharmacokinetics Services Introduction
13.2.4 Pacific BioLabs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
13.2.5 Pacific BioLabs (US) Recent Development
13.3 GVK Biosciences Private Limited (India)
13.3.1 GVK Biosciences Private Limited (India) Company Details
13.3.2 GVK Biosciences Private Limited (India) Business Overview and Its Total Revenue
13.3.3 GVK Biosciences Private Limited (India) Pharmacokinetics Services Introduction
13.3.4 GVK Biosciences Private Limited (India) Revenue in Pharmacokinetics Services Business (2015-2020)
13.3.5 GVK Biosciences Private Limited (India) Recent Development
13.4 Shanghai Medicilon Inc. (China)
13.4.1 Shanghai Medicilon Inc. (China) Company Details
13.4.2 Shanghai Medicilon Inc. (China) Business Overview and Its Total Revenue
13.4.3 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Introduction
13.4.4 Shanghai Medicilon Inc. (China) Revenue in Pharmacokinetics Services Business (2015-2020)
13.4.5 Shanghai Medicilon Inc. (China) Recent Development
13.5 Pharmaceutical Product Development, LLC (US)
13.5.1 Pharmaceutical Product Development, LLC (US) Company Details
13.5.2 Pharmaceutical Product Development, LLC (US) Business Overview and Its Total Revenue
13.5.3 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Introduction
13.5.4 Pharmaceutical Product Development, LLC (US) Revenue in Pharmacokinetics Services Business (2015-2020)
13.5.5 Pharmaceutical Product Development, LLC (US) Recent Development
13.6 Charles River Laboratories International, Inc. (US)
13.6.1 Charles River Laboratories International, Inc. (US) Company Details
13.6.2 Charles River Laboratories International, Inc. (US) Business Overview and Its Total Revenue
13.6.3 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Introduction
13.6.4 Charles River Laboratories International, Inc. (US) Revenue in Pharmacokinetics Services Business (2015-2020)
13.6.5 Charles River Laboratories International, Inc. (US) Recent Development
13.7 PAREXEL International Corporation (US)
13.7.1 PAREXEL International Corporation (US) Company Details
13.7.2 PAREXEL International Corporation (US) Business Overview and Its Total Revenue
13.7.3 PAREXEL International Corporation (US) Pharmacokinetics Services Introduction
13.7.4 PAREXEL International Corporation (US) Revenue in Pharmacokinetics Services Business (2015-2020)
13.7.5 PAREXEL International Corporation (US) Recent Development
13.8 Eurofins Scientific, Inc. (Luxembourg)
13.8.1 Eurofins Scientific, Inc. (Luxembourg) Company Details
13.8.2 Eurofins Scientific, Inc. (Luxembourg) Business Overview and Its Total Revenue
13.8.3 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Introduction
13.8.4 Eurofins Scientific, Inc. (Luxembourg) Revenue in Pharmacokinetics Services Business (2015-2020)
13.8.5 Eurofins Scientific, Inc. (Luxembourg) Recent Development
13.9 Frontage Labs (US)
13.9.1 Frontage Labs (US) Company Details
13.9.2 Frontage Labs (US) Business Overview and Its Total Revenue
13.9.3 Frontage Labs (US) Pharmacokinetics Services Introduction
13.9.4 Frontage Labs (US) Revenue in Pharmacokinetics Services Business (2015-2020)
13.9.5 Frontage Labs (US) Recent Development
13.10 SGS SA (Switzerland)
13.10.1 SGS SA (Switzerland) Company Details
13.10.2 SGS SA (Switzerland) Business Overview and Its Total Revenue
13.10.3 SGS SA (Switzerland) Pharmacokinetics Services Introduction
13.10.4 SGS SA (Switzerland) Revenue in Pharmacokinetics Services Business (2015-2020)
13.10.5 SGS SA (Switzerland) Recent Development
13.11 LGC Limited (UK)
10.11.1 LGC Limited (UK) Company Details
10.11.2 LGC Limited (UK) Business Overview and Its Total Revenue
10.11.3 LGC Limited (UK) Pharmacokinetics Services Introduction
10.11.4 LGC Limited (UK) Revenue in Pharmacokinetics Services Business (2015-2020)
10.11.5 LGC Limited (UK) Recent Development
13.12 Creative Bioarray (US)
10.12.1 Creative Bioarray (US) Company Details
10.12.2 Creative Bioarray (US) Business Overview and Its Total Revenue
10.12.3 Creative Bioarray (US) Pharmacokinetics Services Introduction
10.12.4 Creative Bioarray (US) Revenue in Pharmacokinetics Services Business (2015-2020)
10.12.5 Creative Bioarray (US) Recent Development
13.13 Certara, L.P. (Germany)
10.13.1 Certara, L.P. (Germany) Company Details
10.13.2 Certara, L.P. (Germany) Business Overview and Its Total Revenue
10.13.3 Certara, L.P. (Germany) Pharmacokinetics Services Introduction
10.13.4 Certara, L.P. (Germany) Revenue in Pharmacokinetics Services Business (2015-2020)
10.13.5 Certara, L.P. (Germany) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details